Ireland
# |
Name |
Net Income |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 414.83 M
|
Dec. 31, 2023 | USD 122.96 | -0.16% |
|
Ireland |
|
2 |
USD 355.76 M
|
Dec. 31, 2023 | USD 28.50 | 0.53% |
|
Ireland |
|
3 |
USD -5.19 M
|
Dec. 31, 2023 | USD 0.02 | -6.17% |
|
Ireland |
|
4 |
USD -10.65 M
|
Dec. 31, 2023 | USD 4.34 | 1.19% |
|
Ireland |
|
5 |
USD -35.59 M
|
Dec. 31, 2023 | USD 8.19 | -1.92% |
|
Ireland |
|
6 |
USD -38.37 M
|
Dec. 31, 2023 | USD 1.60 | -2.44% |
|
Ireland |
|
7 |
USD -147.03 M
|
Dec. 31, 2023 | USD 12.67 | -3.50% |
|
Ireland |
|
8 |
USD -160.28 M
|
Dec. 31, 2023 | USD 8.05 | 2.94% |
|
Ireland |
|
9 |
USD -207.45 M
|
Dec. 31, 2023 | USD 3.72 | -0.53% |
|
Ireland |
The Biotechnology company in Ireland with the highest Net Income is Jazz Pharmaceuticals plc (NasdaqGS: JAZZ) at USD 414.83 M.
The Biotechnology company in Ireland with the lowest Net Income is Mural Oncology plc (NasdaqGM: MURA) at USD -207.45 M.
The top 10 Biotechnology companies in Ireland by Net Income are Jazz Pharmaceuticals plc, Alkermes plc, Ovoca Bio plc, kneat.com, inc., GH Research PLC, Iterum Therapeutics plc, Prothena Corporation plc, Avadel Pharmaceuticals plc and Mural Oncology plc.
The bottom 10 Biotechnology companies in Ireland by Net Income are Mural Oncology plc, Avadel Pharmaceuticals plc, Prothena Corporation plc, Iterum Therapeutics plc, GH Research PLC, kneat.com, inc., Ovoca Bio plc, Alkermes plc and Jazz Pharmaceuticals plc.